Biogen (BIIB) gross profit was $11.6B in FY2020 (-6% YoY). The tables below show the complete quarterly and annual gross profit history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual Gross Profit
Fiscal Year
Gross Profit
YoY
2020
$11.6B
-6%
2019
$12.4B
+7%
2018
$11.6B
+9%
2017
$10.6B
+7%
2016
$10.0B
+5%
2015
$9.5B
+12%
2014
$8.5B
+40%
2013
$6.1B
+22%
2012
$5.0B
+8%
2011
$4.6B
+6%
2010
$4.3B
+8%
2009
$4.0B
Recent Quarterly Gross Profit
Quarter
Gross Profit
Q1 2026
$1.8B
Q4 2025
$1.8B
Q3 2025
$1.9B
Q2 2025
$2.0B
Q1 2025
$1.8B
Q4 2024
$1.9B
Q3 2024
$1.8B
Q2 2024
$1.9B
Q1 2024
$1.7B
Q4 2023
$1.8B
Q3 2023
$1.9B
Q2 2023
$1.9B
Source: BIIB on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.